Literature DB >> 11821388

Apoptotic effect of sphingosine 1-phosphate and increased sphingosine 1-phosphate hydrolysis on mesangial cells cultured at low cell density.

Isabelle Gennero1, Josette Fauvel, Michèle Nieto, Clotilde Cariven, Frédérique Gaits, Fabienne Briand-Mésange, Hugues Chap, Jean Pierre Salles.   

Abstract

The lipid mediator sphingosine 1-phosphate (S1P) may alter the proliferation of mesangial cells during pathophysiological processes. Here, S1P stimulated proliferation of rat mesangial cells and phosphorylation of MAPKs at subconfluent cell density. Both effects were inhibited by pertussis toxin treatment. Mesangial cells expressed several S1P receptors of the endothelial differentiation gene family: EDG-1, -3, -5, and -8. Conversely, S1P induced apoptosis at low cell density (2 x 10(4) cells/cm(2)), which was demonstrated by flow cytometry and Hoechst staining. Apoptosis was observed also in quiescent or growing cells and was not reverted by lysophosphatidic acid or platelet-derived growth factor. S1P enhanced phosphorylation of SAPKs. Incubation with [(33)P]S1P, [(3)H]S1P, and [(3)H]sphingosine demonstrated increased S1P hydrolysis, resulting in enhanced intracellular sphingosine levels and decreased S1P levels. A rise in total ceramide levels was also observed; however, ceramide did not originate from [(3)H]sphingosine, and S1P-induced apoptosis was not inhibited by fumonisin B, precluding involvement of de novo ceramide synthesis in apoptosis. Therefore, we suggest that sphingosine accumulation and decreased S1P are primarily responsible for S1P-induced apoptosis. In conclusion, incubation of low-density mesangial cells with S1P results in apoptosis, presumably due to increased S1P hydrolysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11821388     DOI: 10.1074/jbc.M108933200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Extracellular nucleotides induce migration of renal mesangial cells by upregulating sphingosine kinase-1 expression and activity.

Authors:  S Klawitter; L P Hofmann; J Pfeilschifter; A Huwiler
Journal:  Br J Pharmacol       Date:  2007-01-02       Impact factor: 8.739

Review 2.  Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease.

Authors:  S-K Jo; A Bajwa; A S Awad; K R Lynch; M D Okusa
Journal:  Kidney Int       Date:  2008-03-05       Impact factor: 10.612

3.  Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.

Authors:  Tae-Hyun Yoo; Christopher E Pedigo; Johanna Guzman; Mayrin Correa-Medina; Changli Wei; Rodrigo Villarreal; Alla Mitrofanova; Farah Leclercq; Christian Faul; Jing Li; Matthias Kretzler; Robert G Nelson; Markku Lehto; Carol Forsblom; Per-Henrik Groop; Jochen Reiser; George William Burke; Alessia Fornoni; Sandra Merscher
Journal:  J Am Soc Nephrol       Date:  2014-06-12       Impact factor: 10.121

4.  Sphingosine kinase-1 pathway mediates high glucose-induced fibronectin expression in glomerular mesangial cells.

Authors:  Tian Lan; Weihua Liu; Xi Xie; Suowen Xu; Kaipeng Huang; Jing Peng; Xiaoyan Shen; Peiqing Liu; Lijing Wang; Pu Xia; Heqing Huang
Journal:  Mol Endocrinol       Date:  2011-10-13

Review 5.  Sphingolipids and Kidney Disease: Possible Role of Preeclampsia and Intrauterine Growth Restriction (IUGR).

Authors:  Rodrigo Yokota; Benjamin Bhunu; Hiroe Toba; Suttira Intapad
Journal:  Kidney360       Date:  2021-01-07

6.  Increased survival and reduced renal injury in MRL/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist.

Authors:  Scott E Wenderfer; Stanislaw M Stepkowski; Michael C Braun
Journal:  Kidney Int       Date:  2008-09-03       Impact factor: 10.612

7.  Heterologous desensitization of the sphingosine-1-phosphate receptors by purinoceptor activation in renal mesangial cells.

Authors:  Cuiyan Xin; Shuyu Ren; Josef Pfeilschifter; Andrea Huwiler
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

8.  Renal-targeted delivery of triptolide by entrapment in pegylated TRX-20-modified liposomes.

Authors:  Zhi-Xiang Yuan; Lu Jia; Lee Yong Lim; Ju-Chun Lin; Gang Shu; Ling Zhao; Gang Ye; Xiao-Xia Liang; Hongming Ji; Hua-Lin Fu
Journal:  Int J Nanomedicine       Date:  2017-08-08

9.  Sphingosine 1-phosphate triggers apoptotic signal for B16 melanoma cells via ERK and caspase activation.

Authors:  Jeong-Hyun Shin; Gwang-Seong Choi; Won-Hyung Kang; Ki-Bum Myung
Journal:  J Korean Med Sci       Date:  2007-04       Impact factor: 2.153

10.  Spleen tyrosine kinase promotes NLR family pyrin domain containing 3 inflammasome‑mediated IL‑1β secretion via c‑Jun N‑terminal kinase activation and cell apoptosis during diabetic nephropathy.

Authors:  Yingchun Qiao; Xixi Tian; Li Men; Shengyu Li; Yufeng Chen; Meiting Xue; Yahui Hu; Pengfei Zhou; Guangfeng Long; Yue Shi; Ruiqing Liu; Yunde Liu; Zhi Qi; Yujie Cui; Yanna Shen
Journal:  Mol Med Rep       Date:  2018-06-14       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.